Hepatitis C treatment difficult in older patients (Hep C Chronic Fatigue)

Hepatitis C treatment difficult in older patients
New Kerala - NEW YORK: Because of side effects, patients over the age of 60 with hepatitis C find it more difficult to stick with standard treatments than do their younger counterparts, according to a study in Japan. Impaired heart, lung and kidney function can

Tarvacin(TM) Anti-Viral Hepatitis C Clinical Program in Acceleration
RxPG - "The initial success of our efforts to accelerate the HCV clinical trial program for Tarvacin Anti-Viral is gratifying in view of Tarvacin's promise as an important new treatment option for a number of viral infections, including chronic hepatitis C

First-Time Generic Approvals: Copegus, Tegretol, Roxicodone
Medscape News - Jan. 24, 2006 The US Food and Drug Administration (FDA) approved in December 2005 first-time generic 200-mg formulations of ribavirin and carbamazepine tablets, and 15- and 30-mg formulations of oxycodone HCl tablets. First-time doses (ie, no

ALT levels may not give true picture of liver disease in HIV/HCV
Aidsmap - The majority of HIV-positive individuals coinfected with hepatitis C virus who, according to a key blood test, have normal liver function are, in fact, suffering from mild to severe liver damage, according to an Italian study published in the January